Results 151 to 160 of about 104,914 (293)
Optimizing neoadjuvant therapy for muscle‐invasive bladder cancer patients who are eligible for cisplatin remains difficult, owing particularly to high toxicity and recurrence rates. This meta‐analysis compared dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) against durvalumab plus gemcitabine‐cisplatin (D‐GC) and GC alone ...
Maurin Helen Mangold +12 more
wiley +1 more source
Improving Laboratory-Based Cancer Drug Discovery Study Designs for Better Research Translations. [PDF]
Manoharan S.
europepmc +1 more source
This study analyzed 236 heart failure with preserved ejection fraction (HFpEF) pharmacological trials registered on ClinicalTrials.gov from 2003 to 2025, revealing a post‐2016 surge (76.3%), U.S. dominance (58.5%), and prominence of SGLT2 inhibitors/novel therapies (each 13.1%).
Yucheng Hou +6 more
wiley +1 more source
Flow cytometric analysis in sickle cell anemia reveals preserved Treg frequency despite decreased CD25 expression and increased neutrophil activity, highlighting a complex immune imbalance. The proportions of both neutrophil and lymphocyte cells have been shown to be a reliable predictor of CD3+ T cell levels, thus emphasizing the importance of innate ...
Rukiye Ölçüoğlu +7 more
wiley +1 more source
Unraveling the molecular landscape of pancreatic cancer: a systems biology approach to identify therapeutic targets. [PDF]
Ahmadipour E +3 more
europepmc +1 more source
Therapeutic drug monitoring of voriconazole : validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography [PDF]
Cattoir, Lien +5 more
core +1 more source
Thalassemia, a common hereditary blood disorder causing impaired globin synthesis and related complications, has seen remarkable progress in recent years due to advancements in genomics and molecular biology. Researchers have identified various gene variants related to thalassemia and improved clinical diagnostic methods, including new genetic testing ...
Chaoqiong Zhou +7 more
wiley +1 more source
Regulatory, ethical, and clinical barriers to exosome use in interventional pain medicine. [PDF]
Bourcier AJ, Kirkor ZM.
europepmc +1 more source
ABSTRACT Background and Objectives Succinate dehydrogenase‐deficient (SDH‐deficient) gastrointestinal stromal tumors (GIST) are characterized by variable disease biology with poor responses to traditional tyrosine kinase inhibitors. The role of surgical intervention has been highly debated.
Katherine Y. Chen +6 more
wiley +1 more source
Correction: Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders. [PDF]
Detyniecki K +5 more
europepmc +1 more source

